Inactive Instrument

Endo International plc

ENDP

IE00BJ3V9050

BioDelivery Sciences International, Inc. Closes Transaction to Reacquire License to BELBUCA® from Endo Pharmaceuticals

January 09, 2017 at 09:45 am EST

BioDelivery Sciences International, Inc. announced the closing of its previously announced agreement with Endo Pharmaceuticals, Inc. (Endo) terminating Endo's licensing of rights for BELBUCA® (buprenorphine) buccal film (CIII). As a result of the closing, the worldwide rights to BELBUCA have now been transferred back to BDSI.

Latest news about Endo International plc

Transcript : Endo International plc, Q1 2024 Earnings Call, May 31, 2024	May. 31
Endo International plc Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 30	CI
North American Morning Briefing : Stock Futures -2-	May. 06	DJ
Endo International plc Emerged from Bankruptcy	Apr. 23	CI
Fourth Amended Joint Reorganization Plan Approved for Endo International plc	Mar. 22	CI
Health Care Down on Rate Bias -- Health Care Roundup	Mar. 20	DJ
Drugmaker Endo receives US court approval for bankruptcy restructuring	Mar. 19	RE
Drugmaker Endo receives US court approval for bankruptcy restructuring, Bloomberg News reports	Mar. 19	RE
Fourth Amended Joint Reorganization Plan Filed by Endo International plc	Mar. 18	CI
North American Morning Briefing : Stock Futures -2-	Mar. 11	DJ
Health Care Flat After Trial Setbacks -- Health Care Roundup	Mar. 08	DJ
Endo International plc Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Mar. 06	CI
Endo International plc Reports Property, Plant and Equipment Impairment Charges for the Three Months Ended December 31, 2023	Mar. 06	CI
Endo International plc Provides Earnings Guidance for the Year 2024	Mar. 06	CI
Endo International plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 06	CI
Drugmaker Endo reaches $465 mln bankruptcy settlement with US	Feb. 29	RE
Third Amended Joint Reorganization Plan and Disclosure Statement Filed by Endo International plc	Feb. 20	CI
Motion for Exclusivity Period Extension Approved For Endo International plc	Jan. 24	CI
Combined Hearing for Disclosure Statement and Plan Approved for Endo International plc	Jan. 12	CI
PRESS DIGEST-Wall Street Journal - Jan 11	Jan. 11	RE
Second Amended Joint Reorganization Plan and Disclosure Statement Filed by Endo International plc	Jan. 09	CI
First Amended Reorganization Plan and Disclosure Statement Filed by Endo International plc	Jan. 05	CI
Joint Reorganization Plan and Disclosure Statement Filed by Endo International plc	Dec. 18	CI
Third Motion for Exclusivity Period Extension Approved For Endo International plc	Nov. 15	CI
Tranche Update on Endo International plc (OTCPK:ENDP.Q)'s Equity Buyback Plan announced on April 30, 2015.	Nov. 06	CI

Chart Endo International plc

Duration

Period

More charts

Company Profile

Endo International plc has filed a voluntary petition under Chapter 11 of the U.S. Bankruptcy Code and is winding down its business. The Company has no business operations.

Sector

Investment Holding Companies

Calendar

2024-08-05 - Q2 2024 Earnings Release (Projected)

More about the company

Sector Shell Companies

	1st Jan change	Capi.
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+131.89%	7.71B
CHURCHILL CAPITAL CORP VII	+2.67%	987M
PERELLA WEINBERG PARTNERS	+46.93%	961M
ARES ACQUISITION CORPORATION II	+2.39%	668M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
E7 GROUP	-3.05%	582M
ADMIRAL ACQUISITION LIMITED	+10.28%	536M
CAPITOL INVESTMENT CORP. VII	-.--%	500M
AEA-BRIDGES IMPACT CORP.	+3.47%	470M

Shell Companies